Celanese Corporation (NYSE:CE) Given Average Recommendation of “Hold” by Brokerages

Shares of Celanese Corporation (NYSE:CE) have been given an average recommendation of “Hold” by the twenty analysts that are presently covering the firm, MarketBeat reports. Three research analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and six have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $53.2353.

Several equities research analysts have issued reports on CE shares. Citigroup raised their price objective on shares of Celanese from $56.00 to $63.00 and gave the stock a “buy” rating in a research report on Thursday. Wells Fargo & Company reaffirmed an “equal weight” rating and issued a $45.00 price objective (down from $55.00) on shares of Celanese in a report on Friday, December 19th. UBS Group increased their price objective on Celanese from $49.00 to $50.00 and gave the stock a “neutral” rating in a research report on Monday, January 12th. Royal Bank Of Canada boosted their target price on shares of Celanese from $43.00 to $48.00 and gave the company a “sector perform” rating in a research report on Friday. Finally, Bank of America lowered their price target on shares of Celanese from $59.00 to $57.00 and set a “buy” rating on the stock in a research report on Tuesday, October 14th.

Insider Buying and Selling at Celanese

In related news, CFO Chuck Kyrish purchased 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 9th. The stock was acquired at an average cost of $41.03 per share, for a total transaction of $205,150.00. Following the completion of the purchase, the chief financial officer owned 10,914 shares in the company, valued at approximately $447,801.42. This represents a 84.55% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

Hedge Funds Weigh In On Celanese

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. lifted its position in shares of Celanese by 111.1% during the 2nd quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock valued at $28,000 after acquiring an additional 270 shares during the period. SBI Securities Co. Ltd. raised its stake in Celanese by 55.4% in the second quarter. SBI Securities Co. Ltd. now owns 623 shares of the basic materials company’s stock valued at $34,000 after purchasing an additional 222 shares in the last quarter. National Bank of Canada FI bought a new stake in Celanese during the third quarter worth about $34,000. Versant Capital Management Inc grew its stake in Celanese by 140.4% during the third quarter. Versant Capital Management Inc now owns 827 shares of the basic materials company’s stock worth $35,000 after buying an additional 483 shares in the last quarter. Finally, Salomon & Ludwin LLC bought a new position in Celanese in the 3rd quarter valued at about $36,000. 98.87% of the stock is owned by institutional investors and hedge funds.

Celanese Trading Down 0.2%

Shares of Celanese stock opened at $47.07 on Monday. The business’s 50 day moving average is $41.72 and its 200-day moving average is $45.10. Celanese has a 12-month low of $35.13 and a 12-month high of $75.84. The stock has a market cap of $5.15 billion, a P/E ratio of -1.66 and a beta of 1.12. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 2.66.

Celanese (NYSE:CE) last posted its quarterly earnings results on Thursday, November 6th. The basic materials company reported $1.34 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.07. Celanese had a positive return on equity of 9.87% and a negative net margin of 31.85%.The business had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.51 billion. During the same quarter in the prior year, the business earned $2.44 EPS. The firm’s revenue for the quarter was down 8.6% on a year-over-year basis. Celanese has set its Q4 2025 guidance at 0.850-1.000 EPS. Equities research analysts predict that Celanese will post 8.79 earnings per share for the current fiscal year.

About Celanese

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.